Crispr Therapeutics

Yahoo Finance • 3 days ago

Nuvation Bio Inc. (NUVB): A Bull Case Theory

We came across a bullish thesis on Nuvation Bio Inc. on wallstreetbets subreddit by asagi_lumina. In this article, we will summarize the bulls’ thesis on NUVB. Nuvation Bio Inc.'s share was trading at $3.2200 as of September 23rd.AbCellera... Full story

Yahoo Finance • 4 days ago

Recursion Pharmaceuticals, Inc. (RXRX): A Bull Case Theory

We came across a bullish thesis on Recursion Pharmaceuticals, Inc. on Emil Hartela Investing’s Substack by Emil. In this article, we will summarize the bulls’ thesis on RXRX. Recursion Pharmaceuticals, Inc.'s share was trading at $4.6300 a... Full story

Yahoo Finance • 4 days ago

Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead

Key Points CRISPR Therapeutics and BioNTech have climbed along with many of their peers over the past week. Both are innovative biotechs with catalysts that could drive their stocks higher in the next few years. 10 stocks we like better t... Full story

Yahoo Finance • 6 days ago

Advanced Viral Delivery Systems Revolutionizing Gene Therapy for Neurological Disorders

Dublin, Oct. 06, 2025 (GLOBE NEWSWIRE) -- The "Gene Therapy on Neurological Diseases Market Report 2025" has been added to ResearchAndMarkets.com's offering. The gene therapy on neurological diseases market size has grown rapidly in... Full story

Yahoo Finance • 12 days ago

Could This Beaten-Down Stock Help You Become a Millionaire?

Key Points CRISPR Therapeutics has a couple of pipeline candidates with massive opportunities. The company has already shown that it can get approval for its gene-editing medicines. Despte sizable upside potential for the stock, investors... Full story

Yahoo Finance • 17 days ago

Interesting CRSP Put And Call Options For November 7th

Investors in CRISPR Therapeutics AG (Symbol: CRSP) saw new options begin trading today, for the November 7th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRSP options chain for the new November... Full story

Yahoo Finance • 20 days ago

CRISPR Therapeutics and Sirius Therapeutics Announce First Patient Dosed in Phase 2 Trial of SRSD107 for Thromboembolic Disorders in Europe

ZUG, Switzerland and BOSTON and SAN DIEGO and SHANGHAI, Sept. 22, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and... Full story

Yahoo Finance • 24 days ago

CRISPR Therapeutics wins new Overweight rating at J.P. Morgan on pipeline prospects

[Business on Wall Street in Manhattan] Pgiam/iStock via Getty Images CRISPR Therapeutics (NASDAQ:CRSP [https://seekingalpha.com/symbol/CRSP]) traded higher in the premarket on Thursday after J.P. Morgan initiated its coverage with an Over... Full story

Yahoo Finance • 24 days ago

Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises

MarketNewsUpdates News Commentary NEW YORK, Sept. 18, 2025 /PRNewswire/ -- Cell therapy refers to a treatment that involves the use of living cells to treat diseases. The cell therapy market has been experiencing significant growth due to... Full story

Yahoo Finance • last month

CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025

ZUG, Switzerland and BOSTON, Sept. 09, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that a late-bre... Full story

Yahoo Finance • last month

Large-cap biotech is a sector to watch for investors: Analysts

Wall Street is looking for new ways to park cash in healthcare names, and large-cap biotechs have begun to gain steam. This asset class differs from traditional large-cap pharmaceutical companies — typically with a $200 billion market cap... Full story

Yahoo Finance • 2 months ago

Cathie Wood's ARK buys CRISPR, sells Roku and DraftKings stock

Cathie Wood’s ARK ETFs have reported their daily trades for Tuesday, August 26th, 2025, with significant activity in biotech and tech stocks. The largest trade of the day was the purchase of 165,874 shares of CRISPR THERAPEUTICS AG (NASDAQ... Full story

Yahoo Finance • 2 months ago

Cathie Wood's ARK shifts focus, buys CRSP stock, sells ROKU

Cathie Wood’s ARK ETF released their daily trades for Monday, August 25th, 2025, revealing a significant reshuffle in their portfolio. The firm’s largest transaction involved selling 141,194 shares of Roku Inc (NASDAQ:ROKU), amounting to a... Full story

Yahoo Finance • 2 months ago

CRISPR Therapeutics (CRSP) Reports Increase In Q2 Revenue Despite Wider Net Losses

CRISPR Therapeutics recently reported second-quarter results with a significant year-over-year increase in revenue, although net losses also widened. The company's addition to multiple Russell Indices on June 30, 2025, likely buoyed invest... Full story

Yahoo Finance • 2 months ago

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Color Star Technology Co. Ltd. 254,314,419 0.131 0.1142 0.1188 +0.0291 O... Full story

Yahoo Finance • 2 months ago

Cathie Wood's ARK ETF bolsters biotech, trims defense stock

Cathie Wood’s ARK ETF published their daily trades for Monday, August 18th, 2025, showcasing a continued focus on the biotech sector while reducing exposure in defense. The largest trade of the day was the purchase of 170,471 shares of Gen... Full story

Yahoo Finance • 2 months ago

What Makes Crispr Therapeutics Ag (CRSP) a Good Buy?

RGA Investment Advisors, an investment management company, has released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The second quarter-end figures concealed the inherent volatility in the market, w... Full story

Yahoo Finance • 2 months ago

Cathie Wood's ARK ETF focuses on Roblox and CoreWeave stock buys

Cathie Wood’s ARK ETF released its daily trades for Friday, August 15th, 2025, revealing a series of strategic investments and divestments across various sectors. The largest transaction of the day was the purchase of 125,799 shares of Rob... Full story

Yahoo Finance • 2 months ago

Which Gene Therapy Technology Wins? New Data from Spherix Global Insights Reveals Emerging Hematologist Preferences in Beta Thalassemia Care

EXTON, PA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- As the first wave of gene therapies for transfusion-dependent β-thalassemia (TDT) continues to roll out in the U.S., a new conversation is emerging within the hematology community: whether the... Full story

Yahoo Finance • 2 months ago

Cathie Wood's ARK makes major moves in Trade Desk and Block stock

Cathie Wood’s ARK ETFs have once again made significant trades on Tuesday, 12 August 2025, with a major focus on tech and biotech stocks. The most substantial trade of the day was the purchase of 738,367 shares of Trade Desk Inc (NASDAQ:... Full story